Mild alcohol consumption is not associated with increased fibrosis in patients with chronic hepatitis C

Journal of Clinical Gastroenterology

Volumn 45, Issue 1, 2011, Pages 76-82

  Cheung, Onpan ^a   Sterling, Richard K ^a   Salvatori, Jennifer ^a   Williams, Kim ^a   Hubbard, Sarah ^a   Luketic, Velimir A ^a   Stravitz, Todd R ^a   Sanyal, Arun J ^a   Contos, Melissa J ^a   Mills, Scott ^a   Shiffman, Mitchell L ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b Bon Secours Health System   (United States)

Author keywords

alcohol consumption; chronic hepatitis C; fibrosis

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ETHNICITY; FEMALE; GENDER; HEPATITIS C; HUMAN; INFECTION RISK; INTERVIEW; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; ONSET AGE; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; SKINNER ALCOHOL EXAMINATION QUESTIONNAIRE;

ALCOHOL DRINKING; BIOPSY; DISEASE PROGRESSION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 78650959438     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181e12511     Document Type: Article

References (36)

1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556-562.
2. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345:41-52.
3. WHO VHPB. Global surveillance and control of hepatitis C. J Viral Hepat. 1999;6:35-47.
4. Kim WR, Brown RS Jr, Terrault NA, et al. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002;36:227-242.
5. Bellentani S, Pozzato G, Saccoccio G, et al. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut. 1999;44:874-880.
6. Adinolfi LE, Gambardella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology. 2001;33:1358-1364.
7. Chen CM, Yoon YH, Yi HY, et al. Alcohol and hepatitis C mortality among males and females in the United States: a life table analysis. Alcohol Clin Exp Res. 2007;31:285-292.
8. Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. Jama. 2000;284:450-456.
9. Pessione F, Degos F, Marcellin P, et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology. 1998;27:1717-1722.
10. Harris DR, Gonin R, Alter HJ, et al. The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Ann Intern Med. 2001;134: 120-124.
11. Hutchinson SJ, Bird SM, Goldberg DJ. Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol. 2005;3:1150-1159.
12. Skinner HA, Sheu WJ. Reliability of alcohol use indices. The lifetime drinking history and the MAST. J Stud Alcohol. 1982; 43:1157-1170.
13. Pal S, Shuhart MC, Thomassen L, et al. Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo. J Virol. 2006;80:2280-2290.
14. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology. 2000;31:241-246.
15. Fleiss JL, Statistical Methods for Rates and Proportions. 3rd ed. New York: John Wiley and Sons Inc. 2003;308-325.
16. Day CP. Heavy drinking greatly increases the risk of cirrhosis in patients with HCV hepatitis. Gut. 2001;49:750-751.
17. Neal KR, Ramsay S, Thomson BJ, et al. Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study. Gut. 2007;56:1098-1104.
18. Serra MA, Rodriguez F, del Olmo JA, et al. Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage. J Viral Hepat. 2003;10:183-188.
19. Watson JP, Brind AM, Chapman CE, et al. Hepatitis C virus: epidemiology and genotypes in the north east of England. Gut. 1996;38:269-276.
20. de Torres M, Poynard T. Risk factors for liver fibrosis progression in patients with chronic hepatitis C. Ann Hepatol. 2003;2:5-11.
21. PattonHM, Patel K, Behling C, et al. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients. J Hepatol. 2004;40:484-490.
22. Clouston AD, Jonsson JR, Purdie DM, et al. Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation. J Hepatol. 2001;34:314-320.
23. Perlemuter G, Letteron P, Carnot F, et al. Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model. J Hepatol. 2003;39:1020-1027.
24. Perumalswami PV, Bini EJ. Epidemiology, natural history, and treatment of hepatitis B virus and hepatitis C virus coinfection. Minerva Gastroenterol Dietol. 2006;52:145-155.
25. Khan MH, Thomas L, Byth K, et al. How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C? J Gastroenterol Hepatol. 1998;13:419-426.
26. Monto A, Patel K, Bostrom A, et al. Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology. 2004;39:826-834.
27. Wiley TE, McCarthy M, Breidi L, et al. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology. 1998;28:805-809.
28. Hickman IJ, Powell EE, Prins JB, et al. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. J Hepatol. 2003;39:1042-1048.
29. Huang H, Shiffman ML, Cheung RC, et al. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology. 2006;130: 1679-1687.
30. Huang H, Shiffman ML, Friedman S, et al. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology. 2007;46:297-306.
31. Fabris C, Toniutto P, Bitetto D, et al. Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation. J Gastroenterol. 2007;42:543-549.
32. National Institutes of Health Consensus Development Conference Statement.Management of hepatitis C. 2002-June 10-12, 2002. Hepatology. 2002;36:S3-S20.
33. National Hepatitis C Prevention Strategy. Comprehensive strategy for the prevention and control of hepatitis C virus infection and its consequences. [Center for Disease Control and Prevention Web site]. Summer 2001. Available at: http://www.cdc.gov/hepatitis/HCV/Strategy/NatHepCPrevStrategy.htm. Accessed November 1, 2009.
34. Clinical guidelines for the medical management of Hepatitis C. [New York State Department of Health website] 2008. Available at http://www.health.state. ny.us/diseases/communicable/hepatitis/guidelines/epidemiology.htm Accessed November 1, 2009
35. Janszky I, Ljung R, Ahnve S, et al. Alcohol and long-term prognosis after a first acute myocardial infarction: the SHEEP study. Eur Heart J. 2008;29:45-53.
36. Beulens JW, Rimm EB, Ascherio A, et al. Alcohol consumption and risk for coronary heart disease among men with hypertension. Ann Intern Med. 2007;146:10-19.